Smith & Nephew CFO Relocates to US
Ticker: SNNUF · Form: 6-K · Filed: Sep 30, 2025 · CIK: 845982
| Field | Detail |
|---|---|
| Company | Smith & Nephew PLC (SNNUF) |
| Form Type | 6-K |
| Filed Date | Sep 30, 2025 |
| Risk Level | low |
| Pages | 5 |
| Reading Time | 6 min |
| Key Dollar Amounts | $1,013,006, $875,000, $5.8 billion, $0.20 |
| Sentiment | neutral |
Sentiment: neutral
Topics: executive-relocation, management-change, international-operations
Related Tickers: SNN
TL;DR
SNN CFO John Rogers moving to the US, potentially signaling a strategic shift.
AI Summary
Smith & Nephew plc announced on September 30, 2025, that its Chief Financial Officer, John Rogers, will be relocating to the United States. This move is part of the company's ongoing strategic initiatives and aims to enhance its global operational presence.
Why It Matters
The relocation of a key executive like the CFO to the United States could signal a strategic shift or increased focus on the North American market for Smith & Nephew.
Risk Assessment
Risk Level: low — This filing is an informational update regarding executive relocation and does not contain significant financial or operational changes that would typically increase risk.
Key Players & Entities
- Smith & Nephew plc (company) — The company making the announcement.
- John Rogers (person) — Chief Financial Officer of Smith & Nephew.
- September 30, 2025 (date) — Date of the filing and announcement.
- LSE:SN (company) — London Stock Exchange ticker for Smith & Nephew.
- NYSE:SNN (company) — New York Stock Exchange ticker for Smith & Nephew.
FAQ
What is the primary purpose of this Form 6-K filing?
The primary purpose is to announce the relocation of Smith & Nephew's Chief Financial Officer, John Rogers, to the United States.
Who is John Rogers and what is his role at Smith & Nephew?
John Rogers is the Chief Financial Officer (CFO) of Smith & Nephew.
When was this announcement made?
The announcement was made on September 30, 2025.
What are the stock exchange tickers for Smith & Nephew?
Smith & Nephew is listed on the London Stock Exchange under the ticker SN (LSE:SN) and on the New York Stock Exchange under the ticker SNN (NYSE:SNN).
Does this filing indicate a change in Smith & Nephew's reporting requirements?
No, the filing indicates that Smith & Nephew files annual reports under Form 20-F, which is typical for a foreign private issuer.
Filing Stats: 1,584 words · 6 min read · ~5 pages · Grade level 16.1 · Accepted 2025-09-30 07:11:35
Key Financial Figures
- $1,013,006 — will be reduced from £750,375, or $1,013,006 at current exchange rates, to $875,000;
- $875,000 — 1,013,006 at current exchange rates, to $875,000;   ●     
- $5.8 billion — countries and generated annual sales of $5.8 billion in 2024. Smith+Nephew is a constituent
- $0.20 — er 2025, the following awards of US$0.20 ordinary shares (the "Shares") in
Filing Documents
- a2644b.htm (6-K) — 47KB
- 0001654954-25-011207.txt ( ) — 48KB
Forward-looking Statements
Forward-looking Statements This document may contain forward-looking statements that may or may not prove accurate. For example, statements regarding expected revenue growth and trading profit margins, market trends and our product pipeline are forward-looking statements. Phrases such as "aim", "plan", "intend", "anticipate", "well-placed", "believe", "estimate", "expect", "target", "consider" and similar expressions are generally intended to identify forward-looking statements.
Forward-looking statements involve known and unknown risks,
Forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause actual results to differ materially from what is expressed or implied by the statements. For Smith+Nephew, these factors include: conflicts in Europe and the Middle East, economic and financial conditions in the markets we serve, especially those affecting healthcare providers, payers and customers; price levels for established and innovative medical devices; developments in medical technology; regulatory approvals, reimbursement decisions or other government actions; product defects or recalls or other problems with quality management systems or failure to comply with related regulations; litigation relating to patent or other claims; legal and financial compliance risks and related investigative, remedial or enforcement actions; disruption to our supply chain or operations or those of our suppliers; competition for qualified personnel; strategic actions, including acquisitions and disposals, our success in performing due diligence, valuing and integrating acquired businesses; disruption that may result from transactions or other changes we make in our business plans or organisation to adapt to market developments; relationships with healthcare professionals; reliance on information technology and cybersecurity; disruptions due to natural disasters, weather and climate change related events; changes in customer and other stakeholder sustainability expectations; changes in taxation regulations; effects of foreign exchange volatility; and numerous other matters that affect us or our markets, including those of a political, economic, business, competitive or reputational nature. Please refer to the documents that Smith+Nephew has filed with the U.S. Securities and Exchange Commission under the U.S. Securities Exchange Act of 1934, as amended, including Smith+Nephew's most recent annual report on Form 20-F, which is available on the SEC's website at ww
SIGNATURES
SIGNATURES   Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.             Smith & Nephew plc     (Registrant)             Date: September 30, 2025 By: /s/ Helen Barraclough     Helen Barraclough     Company Secretary